Back
Crinetics Pharmaceuticals Stock Price Chart
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.
Sell
30
CRNX
Crinetics Pharmaceuticals
Last Price:
$53.74
Seasonality Move:
-9.59%
7 Day Trial
ALL ACCESS PASS
$
7
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRNX is experiencing slight selling pressure.
Crinetics Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 53.74 | Buy |
| 20-day SMA: | 55.94 | Sell |
| 50-day SMA: | 56.86 | Sell |
| 200-day SMA: | 50.6 | Buy |
| 8-day EMA: | 54.19 | Sell |
| 20-day EMA: | 55.29 | Sell |
| 50-day EMA: | 55.59 | Sell |
| 200-day EMA: | 49.85 | Buy |
Crinetics Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.9 | Sell |
| Relative Strength Index (14 RSI): | 44.61 | Sell |
| Chaikin Money Flow: | -4611 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (54.09 - 57.85) | Sell |
| Bollinger Bands (100): | (51.21 - 57.49) | Sell |
Crinetics Pharmaceuticals Technical Analysis
| Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Crinetics Pharmaceuticals Stock
Is Crinetics Pharmaceuticals Stock a Buy?
-
Crinetics Pharmaceuticals share price is 53.94 while CRNX 8-day simple moving average is 53.74, which is a Buy signal.
-
The stock price of CRNX is 53.94 while Crinetics Pharmaceuticals 20-day SMA is 55.94, which makes it a Sell.
-
Crinetics Pharmaceuticals 50-day simple moving average is 56.86 while CRNX share price is 53.94, making it a Sell technically.
-
CRNX stock price is 53.94 and Crinetics Pharmaceuticals 200-day simple moving average is 50.60, creating a Buy signal.
CRNX Technical Analysis vs Fundamental Analysis
Sell
30
Crinetics Pharmaceuticals (CRNX)
is a Sell
Is Crinetics Pharmaceuticals a Buy or a Sell?
-
Crinetics Pharmaceuticals stock is rated a SellThe current Crinetics Pharmaceuticals [CRNX] share price is $53.94. The Score for CRNX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
Crinetics Pharmaceuticals Stock Info
Market Cap:
5B
Price in USD:
53.94
Share Volume:
150.3K
Crinetics Pharmaceuticals 52-Week Range
52-Week High:
62.53
52-Week Low:
33.67
Sell
30
Crinetics Pharmaceuticals (CRNX)
is a Sell
Crinetics Pharmaceuticals Share Price Forecast
-
What is the Crinetics Pharmaceuticals stock price today?The Crinetics Pharmaceuticals stock price is 53.94 USD today.
-
Will CRNX stock go up or go down?Crinetics Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Crinetics Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Crinetics Pharmaceuticals is overvalued.
Is Crinetics Pharmaceuticals Stock a Buy?
-
Crinetics Pharmaceuticals share price is 53.94 while CRNX 8-day exponential moving average is 54.19, which is a Sell signal.
-
The stock price of CRNX is 53.94 while Crinetics Pharmaceuticals 20-day EMA is 55.29, which makes it a Sell.
-
Crinetics Pharmaceuticals 50-day exponential moving average is 55.59 while CRNX share price is 53.94, making it a Sell technically.
-
CRNX stock price is 53.94 and Crinetics Pharmaceuticals 200-day simple moving average is 49.85, creating a Buy signal.
Fundamental Analysis of Crinetics Pharmaceuticals
Is Crinetics Pharmaceuticals a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.06 per share, and a decrease next year of $0.18 per share.
Technical Analysis of Crinetics Pharmaceuticals
Should I short Crinetics Pharmaceuticals stock?
-
CRNX Moving Average Covergence Divergence (MACD) indicator is -0.9, suggesting Crinetics Pharmaceuticals is a Sell
-
Crinetics Pharmaceuticals Relative Strength Index (RSI) is 44.61, which suggest Crinetics Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Crinetics Pharmaceuticals is (54.09 - 57.85), which suggest Crinetics Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Crinetics Pharmaceuticals is (51.21 - 57.49), which suggest Crinetics Pharmaceuticals is a Sell
* Crinetics Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.